#Non-invasive Coronary Imaging Market 2023

[neha24blog]

Non-invasive Coronary Imaging Market Segmented On The Basis Of Modality, End-Use, Region And Forecast 2030: Grand View Research Inc.

San Francisco, 9 March 2023: The Report Non-invasive Coronary Imaging Market Size, Share & Trends Analysis Report By Modality (Radionuclide Imaging, Echocardiography, CAT, CMR), By End-use, By Region, And Segment Forecasts, 2023 – 2030 The global non-invasive coronary imaging market size is expected to reach USD 0.24 billion by the end of 2030, according to a new report by Grand View Research,…

[insightfulblogz]

Echocardiography Market Future Growth, Scope, Price, and Forecast 2032

Echocardiography, a non-invasive imaging technique, has become one of the most essential tools in cardiovascular diagnostics. It uses high-frequency sound waves (ultrasound) to create detailed images of the heart, allowing physicians to assess its structure, function, and blood flow in real-time. This diagnostic tool is widely used to evaluate heart conditions such as heart failure, valve diseases, congenital heart defects, and cardiomyopathy. Its non-invasive nature, coupled with its ability to provide quick, accurate results, makes echocardiography a cornerstone in modern cardiology, offering valuable insights into heart health without the need for surgery.

The Echocardiography Market was estimated at USD 2.01 billion in 2023 and is expected to reach USD 3.54 billion by 2031 and is anticipated to increase at a CAGR of 7.21% predicted for the forecast period of 2024-2031.

Future Scope

The future of echocardiography is poised for further advancements, particularly with the integration of artificial intelligence (AI) and 3D imaging. AI algorithms are being developed to assist in image interpretation, improving diagnostic accuracy and reducing the time required for analysis. Portable echocardiography devices are becoming increasingly common, allowing for point-of-care diagnostics in emergency settings and remote areas. The development of more advanced imaging techniques, such as strain imaging and 4D echocardiography, will enable even more precise assessments of heart function and early detection of diseases. These advancements will enhance the diagnostic capabilities of echocardiography and expand its applications in personalized cardiovascular care.

Trends

Several trends are shaping the evolution of echocardiography. One major trend is the use of handheld and portable devices, making it more accessible for use outside of traditional hospital settings. Telemedicine and remote diagnostics are also gaining traction, allowing cardiologists to interpret echocardiograms from a distance and provide timely consultations. The increasing application of 3D and 4D echocardiography is another key trend, offering more detailed views of the heart's structures and dynamic function. AI-powered echocardiography is emerging as a transformative tool, providing automated measurements and advanced diagnostic capabilities, enabling faster and more accurate assessments.

Applications

Echocardiography is applied in numerous cardiac evaluations, from routine check-ups to complex diagnostic procedures. It plays a crucial role in diagnosing conditions like heart valve disease, heart failure, and atrial fibrillation. Stress echocardiography, a variation of the technique, is used to assess heart function under physical exertion, aiding in the diagnosis of coronary artery disease. Echocardiography is also essential for monitoring patients post-cardiac surgery, helping physicians evaluate the success of interventions and detect any complications early. Additionally, it is widely used in pediatric cardiology to diagnose congenital heart defects in newborns and children.

Get a Free Sample Guide: https://www.snsinsider.com/sample-request/2853 

Key Points

Echocardiography is a non-invasive imaging technique that evaluates heart structure, function, and blood flow.

It is widely used in the diagnosis of heart conditions such as valve disease, heart failure, and congenital defects.

Future developments include AI integration, 3D and 4D imaging, and the rise of portable devices.

Echocardiography plays a vital role in routine diagnostics, stress testing, and post-surgical monitoring.

Conclusion

Echocardiography continues to be a critical diagnostic tool in cardiovascular medicine, providing invaluable insights into heart health. Its non-invasive nature, combined with ongoing technological advancements, ensures that echocardiography remains a key component in the early detection and management of heart disease. As AI, 3D imaging, and portable devices become more integrated into clinical practice, the scope of echocardiography will expand, allowing for more precise, accessible, and efficient heart diagnostics. This evolution promises to improve patient outcomes and reduce the burden of cardiovascular diseases worldwide.

[alicesara611]

Harnessing the Power of Technology: Portable Vascular Doppler Devices Revolutionize Vascular Imaging By 2023 to 2030

The portable vascular doppler market is expected to grow at a CAGR of 7.5% from 2023 to 2030, reaching a value of US$ 2.2 billion by 2030, The growth of this market is being driven by several factors, including the increasing prevalence of cardiovascular diseases, the growing demand for minimally invasive procedures, and the rising adoption of portable vascular doppler devices in home healthcare settings.

Portable vascular doppler devices are used to assess blood flow and circulation in the body. These devices are non-invasive and easy to use, making them a popular choice for both medical professionals and home healthcare users. The devices are available in a variety of sizes and configurations, and can be used to assess blood flow in a variety of locations, including the arms, legs, neck, and abdomen.

Get your Sample Report with Latest Market Information! https://absolutemarketresearch.com/Global-Portable-Vascular-Doppler-Market/1700/request-sample

The increasing prevalence of cardiovascular diseases, such as coronary artery disease (CAD), peripheral artery disease (PAD), and venous thromboembolism (VTE), is the primary factor driving growth of the portable vascular doppler market. These diseases are major causes of morbidity and mortality worldwide, and portable vascular dopplers are essential diagnostic tools for their early detection and management.

In addition, the rising adoption of minimally invasive procedures, such as endovascular therapies, is also contributing to the growth of the portable vascular doppler market. These procedures require real-time visualization of blood flow, which can be effectively provided by portable vascular dopplers.

Furthermore, the increasing demand for point-of-care (POC) testing is also driving the growth of the portable vascular doppler market. POC testing allows healthcare providers to make rapid diagnoses and treatment decisions, which can improve patient outcomes.

North America is the largest market for portable vascular dopplers, followed by Europe and Asia Pacific. The growth of the North American market is being driven by the high prevalence of cardiovascular diseases and the increasing adoption of minimally invasive procedures. The European market is also growing steadily, due to the increasing demand for POC testing and the rising prevalence of cardiovascular diseases. The Asia Pacific market is the fastest growing market, due to the increasing economic development and the rising prevalence of cardiovascular diseases.

Market Drivers:

There are several factors driving the growth of the portable vascular doppler market, including:

Rising prevalence of PAD: PAD is a condition that affects over 200 million people worldwide. It is a major cause of cardiovascular disease and death. The increasing prevalence of PAD is driving the demand for portable vascular doppler devices, which can be used to diagnose and monitor PAD.

Growing aging population: The global aging population is expected to reach 2 billion by 2050. Older adults are more likely to develop PAD, which is driving the demand for portable vascular doppler devices.

Increasing demand for minimally invasive procedures: Minimally invasive procedures are becoming increasingly popular, as they are associated with fewer complications and shorter recovery times. Portable vascular doppler devices are often used in minimally invasive procedures, which is driving the demand for these devices.

Key Takeaways:

The Portable Vascular Doppler Market is expected to grow at a CAGR of 7.5% from 2023 to 2030, reaching a value of US$ 2.2 billion by 2030.

The market is driven by the increasing prevalence of vascular diseases, the growing aging population, and the rising demand for minimally invasive procedures.

North America is expected to be the largest market for portable vascular Dopplers, followed by Europe and Asia Pacific.

Regional Outlook:

North America is expected to hold the largest market share of the global portable vascular Doppler market, owing to the high prevalence of vascular diseases, the presence of leading market players, and the well-established healthcare infrastructure in the region.

Europe is expected to be the second-largest market for portable vascular Dopplers, driven by the increasing demand for minimally invasive procedures and the growing awareness of vascular diseases in the region.

Asia Pacific is expected to be the fastest-growing market for portable vascular Dopplers, owing to the rising prevalence of vascular diseases, the growing aging population, and the increasing adoption of minimally invasive procedures in the region.

Key Players:

GE Healthcare

Siemens Healthineers

Koninklijke Philips N.V.

Hitachi Ltd.

Esaote SpA

Samsung Medison Co., Ltd

Mindray Medical International Limited

Analogic Corporation

FUJIFILM Sonosite Inc.

Huntleigh Medical

Spengler Holtec Medical GmbH

doppler ultrasound systems

Bionano Genomics

VTI Medical Technology

Segmentation:

By Portability:

Handheld Doppler Ultrasound System

Trolley-based Doppler Ultrasound System

By Application:

Obstetrics and Gynecology

Radiology

Cardiology

Others

By End User:

Hospitals

Clinics

Diagnostic Centers

Others

[healthcareandconsultigblogs]

Atherosclerosis Market: Innovations and Opportunities 

Atherosclerosis, a chronic cardiovascular condition characterized by the buildup of plaque in arteries, remains a significant global health concern. As the prevalence of atherosclerosis continues to rise, the atherosclerosis market has become a focal point for innovation and investment. This article explores the current landscape of the atherosclerosis market, highlighting key developments, emerging trends, and opportunities for growth.

Read more about Atherosclerosis Market Dynamics at::

https://www.prnewswire.co.uk/news-releases/atherosclerosis-market-to-witness-growth-by-2032-estimates-delveinsight--leading-companies---csl-behring-novartis-merck-amgen-ionis--biomarin-astrazeneca-301891247.html

http://www.prnewswire.com/news-releases/atherosclerosis-market-to-witness-growth-by-2032-estimates-delveinsight--leading-companies---csl-behring-novartis-merck-amgen-ionis--biomarin-astrazeneca-301891245.html

https://finance.yahoo.com/news/atherosclerosis-market-witness-growth-2032-210100479.html

https://www.marketwatch.com/press-release/atherosclerosis-market-to-witness-growth-by-2032-estimates-delveinsight-leading-companies-csl-behring-novartis-merck-amgen-ionis-biomarin-astrazeneca-7677f0d9?mod=search_headline

https://www.prnewswire.com/news-releases/atherosclerosis-market-to-witness-growth-by-2032-estimates-delveinsight--leading-companies---csl-behring-novartis-merck-amgen-ionis--biomarin-astrazeneca-301891245.html

Increasing Atherosclerosis Burden

The atherosclerosis market is primarily driven by the escalating disease burden. Atherosclerosis is a major contributor to heart attacks and strokes, leading to substantial healthcare costs and mortality rates worldwide. The growing aging population and rising prevalence of risk factors like obesity and diabetes further amplify the market's significance.

Read how Atherosclerosis market is rising in the upcoming years:

https://www.benzinga.com/pressreleases/23/08/n33533883/atherosclerosis-market-to-witness-growth-by-2032-estimates-delveinsight-leading-companies-csl-behr

https://www.finanzen.net/nachricht/aktien/atherosclerosis-market-to-witness-growth-by-2032-estimates-delveinsight-leading-companies-csl-behring-novartis-merck-amgen-ionis-biomarin-astrazeneca-12699339

http://www.wfmz.com/news/pr_newswire/pr_newswire_health/atherosclerosis-market-to-witness-growth-by-2032-estimates-delveinsight-leading-companies---csl-behring/article_36456dcc-416e-56a0-a104-c22f6d3a2de2.html

https://www.finanznachrichten.de/nachrichten-2023-08/59743961-delveinsight-business-research-llp-atherosclerosis-market-to-witness-growth-by-2032-estimates-delveinsight-leading-companies-csl-behring-novar-008.htm

https://ceo.ca/@newswire/atherosclerosis-market-to-witness-growth-by-2032-estimates

Atherosclerosis Diagnostic Advancements

In recent years, diagnostic advancements have revolutionized the atherosclerosis market. Non-invasive imaging techniques, such as coronary CT angiography and carotid ultrasound, have enhanced early detection, enabling timely intervention and reducing the disease's progression.

Click through the links below to find more about Atherosclerosis Diagnosis Methods:

https://pr.taosnews.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://smb.shelbycountyreporter.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

http://www.onenewspage.com/prnewswire.php?rkey=20230802IO73071&filter=3968

http://www.onenewspage.com/prnewswire.php?rkey=20230802EN73071&filter=3968

https://smb.salisburypost.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

Atherosclerosis Therapeutic Approaches

Pharmaceutical companies are continually developing innovative therapeutic approaches for atherosclerosis. Statins, which lower cholesterol levels, remain a cornerstone of treatment, but novel drugs targeting inflammation and lipid metabolism are on the horizon. PCSK9 inhibitors and RNA-targeted therapies are gaining prominence.

To know more about Atherosclerosis Therapeutic Approches, visit:

https://smb.natchezdemocrat.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://www.topionetworks.com/press_releases/64cac4ba3eb5815574359d6d

https://pr.jewishlink.news/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://smb.albertleatribune.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://smb.magnoliastatelive.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

Atherosclerosis Interventional Procedures

The interventional segment of the atherosclerosis market has witnessed remarkable growth. Minimally invasive procedures like angioplasty and stent placement have become routine interventions for patients with severe atherosclerotic disease. Bioresorbable stents are a promising area of research, potentially reducing long-term complications.

Read more about Atherosclerosis Interventional Procedures at:

https://smb.vicksburgpost.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://smb.panews.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://smb.lagrangenews.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://smb.americanpress.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://smb.state-journal.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

Lifestyle Modifications for treating Atherosclerosis

Lifestyle modifications remain crucial in managing atherosclerosis. Patients are increasingly adopting healthier lifestyles, including diet changes, exercise, and smoking cessation, reflecting a shift toward preventive care.

Know how can Atherosclerosis be treated naturally at:

https://smb.picayuneitem.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://smb.thecoastlandtimes.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://www.bayariq.net/p/norway.html?rkey=20230802EN73071&filter=26014

https://www.bayariq.net/p/denmark.html?rkey=20230802EN73071&filter=26006

https://smb.alexcityoutlook.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

Personalized Medicines for Atherosclerosis

Advancements in genomics and biomarker discovery have paved the way for personalized medicine in atherosclerosis treatment. Tailoring therapies to an individual's genetic makeup and risk factors holds great potential for optimizing treatment outcomes.

Get your personalized Atherosclerosis Medicines at:

https://smb.dailyleader.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://smb.lobservateur.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://smb.austindailyherald.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://smb.leaderpub.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://smb.oxfordeagle.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

Atherosclerosis Market Competition

The atherosclerosis market is highly competitive, with several pharmaceutical giants vying for dominance. Novartis, Amgen, and Pfizer are among the key players, continually investing in research and development to stay ahead in the race for innovative therapies.

To know more about Atherosclerosis Market Competition, click:

https://smb.farmvilleherald.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://smb.elizabethton.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://pr.boreal.org/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://smb.smithfieldtimes.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://smb.troymessenger.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

Atherosclerosis Market Challenges

Despite significant progress, the atherosclerosis market faces challenges, including drug pricing pressures and the need for long-term patient adherence to treatment regimens. Managing these challenges will be essential for sustainable growth.

Click to know more about Atherosclerosis Market challenges:

https://smb.suffolknewsherald.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://smb.winchestersun.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://smb.thewashingtondailynews.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://smb.andalusiastarnews.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://smb.thesnaponline.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

Emerging Atherosclerosis Market

Atherosclerosis is not confined to developed countries. Emerging markets in Asia, Latin America, and the Middle East are witnessing a surge in atherosclerotic diseases, offering immense growth potential for companies willing to expand their reach.

Know how the Atherosclerosis Market is emerging over the upcoming years: 

https://smb.irontontribune.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://uk-times.com/pr-newswire/?rkey=20230802EN73071&filter=24927

https://smb.clantonadvertiser.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://smb.valleytimes-news.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://smb.amnews.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

The atherosclerosis market is poised for continued growth and innovation as it tackles the pressing global health issue of plaque buildup in arteries. Advances in diagnostics, therapeutics, and interventional procedures, coupled with a growing focus on personalized medicine and lifestyle modifications, hold promise for improved patient outcomes and a brighter future in the fight against atherosclerosis. As research and development efforts persist, the atherosclerosis market will remain a dynamic and essential sector of the healthcare industry.

Click to know more about Atherosclerosis Market Trends, Drivers, Barriers, Companies Working, and Therapies involved at:

https://www.newdelhitimes.com/news-release/?rkey=20230802EN73071&filter=5147

https://smb.tryondailybulletin.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://smb.orangeleader.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://smb.thewetumpkaherald.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://smb.greenvilleadvocate.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://smb.selmatimesjournal.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://smb.roanoke-chowannewsherald.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://smb.thepostsearchlight.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

http://www.nighthelper.com/press-room/?rkey=20230802IO73071&filter=5235

https://smb.thetidewaternews.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

[desaletushki]

Cardiovascular Ultrasound Market Size, Share & Trends Analysis Report, 2030

The global cardiovascular ultrasound market size is expected to reach USD 4.01 billion by 2030 and expand at a CAGR of 4.96% during the forecast period, based on a new report by Grand View Research, Inc. The primary factor driving cardiovascular ultrasounds is that new imaging technologies have improved the accuracy and resolution of images obtained from echocardiography machines. This makes it easier for clinicians to identify and diagnose diseases. Additionally, it provides non-invasive diagnostic options, which are often preferred over invasive procedures.

Request Sample Report: https://www.grandviewresearch.com/industry-analysis/cardiovascular-ultrasound-system-market/request/rs15?utm_source=medium&utm_medium=referral&utm_campaign=tushar-d_ict_3-july-23&utm_term=cardiovascular-ultrasound-system-market&utm_content=request_sample

Benefits associated with cardiovascular ultrasound over conventional methods include quick recovery, reduced span of hospitalization, and fewer post-operative complications. These benefits along with the rising geriatric population are expected to propel the demand for cardiovascular ultrasound diagnosis over the forecast period.

North America captured the largest market share in 2022. A favorable reimbursement framework and the presence of a large number of industry players are some of the major factors which can be attributed to regional growth. The rising geriatric population coupled with sophisticated healthcare infrastructure is expected to further fuel market growth in the region. Furthermore, increasing health awareness is driving demand.

COVID-19 has had a significant impact on CVUS. One of the most noticeable effects of the pandemic has been the delays in elective procedures, including those related to CVUS. As a result, which reduces the demand for imaging equipment and services. However, the pandemic has also led to an increase in telemedicine adoption, which includes the use of remote monitoring devices and virtual consultations. This led to increased use of portable devices and an expansion of the market.

Cardiovascular Ultrasound Market Report Highlights

The cardiovascular ultrasound in the healthcare market size was estimated at USD 2.69 billion in 2022 and is expected to reach USD 4.01 billion in 2023

The global cardiovascular ultrasound in the healthcare market is expected to expand at a compound annual growth rate of 4.96% from 2022 to 2030 to reach USD 4.01 billion by 2030

In 2022, North America dominated the market in terms of the revenue share of 29.1%. The market's growth in the region is increasing due to an increase in cardiovascular diseases across the region

Cardiovascular Ultrasound Market Segmentation

Grand View Research has segmented the Cardiovascular ultrasounds based on type, technology, display, end-use:

Cardiovascular Ultrasound Type Outlook (Revenue, USD Million, 2018 - 2030)

Transthoracic Echocardiography

Transesophageal Echocardiography

Fetal Echocardiography

Others

Cardiovascular Ultrasound Technology Outlook (Revenue, USD Million, 2018 - 2030)

2D

3D/4D

Doppler

Cardiovascular Ultrasound Display Outlook (Revenue, USD Million, 2018 - 2030)

B/W

Color

Cardiovascular Ultrasound End-use Outlook (Revenue, USD Million, 2018 - 2030)

Hospital

Diagnostic Centers

Ambulatory Care Centers

Other

Regional Insights

North America dominated the global market and accounted for a revenue share of 29.1% in 2022. This is attributed to cardiovascular disease which is one of the leading causes of death in the region, with conditions such as coronary artery disease, hypertension, and heart failure affecting a significant proportion of the population. This has led to a greater demand for diagnostic tools, such as cardiovascular ultrasound, to assess and monitor cardiovascular health.

The Asia Pacific region is expected to grow at the fastest CAGR of 5.37% owning to advancements in technology that have made cardiovascular ultrasound machines more accurate, efficient, and accessible. Additionally, economic growth in the region has led to an expansion of the middle class and increased healthcare spending. This has led to greater demand for advanced medical technologies, including cardiovascular ultrasound.

List of Key Players in the Cardiovascular Ultrasound Market

GE Healthcare

Koninklijke Philips

Siemens Healthineers AG

Hitachi Medical Corp.

Samsung Medison Co. Ltd.

Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (Mindray)

Chison Wuxi Xiangsheng Medical Technology Co., Ltd.

Fujifilm Sonosite, Inc.

Buy Full Report: https://www.grandviewresearch.com/checkout/select-license/cardiovascular-ultrasound-system-market?utm_source=medium&utm_medium=referral&utm_campaign=tushar-d_ict_3-july-23&utm_term=cardiovascular-ultrasound-system-market&utm_content=request_sample

[techninja]

Cardiovascular Monitoring and Diagnostic Devices Market Poised for Steady Growth in 2023

Introduction:

The global cardiovascular monitoring and diagnostic devices market is set to witness substantial growth in 2023, driven by advancements in technology, rising prevalence of cardiovascular diseases, and increasing awareness about early detection and prevention. These devices play a pivotal role in the diagnosis, monitoring, and management of cardiovascular conditions, enabling healthcare professionals to provide timely interventions and improve patient outcomes. With a focus on precision, portability, and user-friendliness, manufacturers are introducing innovative solutions that are revolutionizing cardiovascular care.

Growing Prevalence of Cardiovascular Diseases:

Cardiovascular diseases, including heart attacks, strokes, and coronary artery diseases, remain the leading cause of mortality worldwide. The increasing prevalence of risk factors such as obesity, sedentary lifestyles, unhealthy diets, and tobacco use continues to contribute to the burden of cardiovascular diseases. As a result, there is a pressing need for effective monitoring and diagnostic devices to detect and manage these conditions.

Technological Advancements Driving Market Growth:

Technological advancements have significantly improved the capabilities and efficiency of cardiovascular monitoring and diagnostic devices. Wearable devices, such as smartwatches and fitness bands, equipped with heart rate monitors and electrocardiogram (ECG) sensors, are gaining popularity among consumers. These devices allow individuals to track their heart health in real-time and provide valuable data to healthcare professionals.

Moreover, advancements in non-invasive imaging techniques, such as cardiac magnetic resonance imaging (MRI) and computed tomography (CT) scans, have improved the accuracy and efficiency of cardiovascular diagnosis. These imaging modalities provide detailed anatomical information, allowing healthcare providers to make informed decisions regarding treatment plans.

Increasing Emphasis on Remote Monitoring:

The COVID-19 pandemic has underscored the importance of remote monitoring in healthcare. With restrictions on in-person visits, remote monitoring devices have become indispensable tools in managing cardiovascular conditions. Remote monitoring enables healthcare professionals to track patients' vital signs, such as heart rate, blood pressure, and oxygen saturation, from a distance. This technology ensures timely intervention and reduces the risk of complications, especially for high-risk patients.

Market Outlook for 2023:

The cardiovascular monitoring and diagnostic devices market is expected to experience steady growth in 2023. The market will be driven by the increasing adoption of wearable devices and the growing demand for non-invasive diagnostic tools. Additionally, the aging population and the rising prevalence of chronic diseases will contribute to market growth.

Emerging economies, particularly in Asia-Pacific and Latin America, present significant opportunities for market players. The expanding healthcare infrastructure, improving reimbursement policies, and increasing disposable income in these regions are expected to fuel market growth. Furthermore, collaborations between device manufacturers and healthcare providers are likely to drive innovation and the development of cost-effective solutions tailored to regional needs.

Conclusion:

The cardiovascular monitoring and diagnostic devices market is poised for steady growth in 2023, driven by technological advancements, the rising prevalence of cardiovascular diseases, and the emphasis on remote monitoring. These devices have the potential to improve patient outcomes by enabling early detection, accurate diagnosis, and timely interventions. As the industry continues to evolve, manufacturers and healthcare providers must collaborate to develop innovative solutions that enhance cardiovascular care and improve patient well-being.

[wiseguy-reports]

The Optical coherence tomography (OCT) is a kind of imaging technology which is non-invasive in nature. The OCT is a device that helps in the generation of the duplicate-color depiction of the tissue structure, directly on the micron scale in real and in situ times. It is parallel to the ultrasound imaging, except the fact that it makes use of the light instead of using the sound. OCT has been developed as a standout amongst the most essential imaging strategy in different restorative applications. OCT is an optical analog of the intravascular ultrasound in the cardiology section, used to analyze the coronary arteries. The global optical coherence tomography market is anticipated to grow rapidly at a CAGR of 8.9% during the estimation period (2017-2023). The global market is anticipated to reach the value of USD 1483.49 million by the year 2023.

[market-research-future]

Optical Coherence Tomography Market Size | Dynamics and Growth | Forecast To 2023

Optical Coherence Tomography (OCT) Market Overview

The Global Optical Coherence Tomography Market is likely to reach a significant valuation of USD 1483.49 Million by 2023 says Market Research Future (MRFR). Optical coherence tomography (OCT) is a non-invasive imaging technology used in attaining detailed images at a microscopic level. It employs near-infrared lighting to obtain clear images in real-time. The sharp rise noticed in eye-related diseases among the geriatric populace and industrial applications will induce the demand for OCT.

Market Outlook

The Global Optical Coherence Tomography Market valuation can touch USD 1483.9 million by 2023, as per the latest report by Market Research Future (MRFR). Technological advances in imaging devices coupled with high prevalence of macular disorders are likely to fuel the market growth.

Request Free Sample Report at: https://www.marketresearchfuture.com/sample_request/1328

Favorable medical reimbursement schemes regarding eye diseases and approval from regulatory agencies can propel the market to experience an 8.9% CAGR from 2017 to 2023 (forecast period). Furthermore, government support for the technology is likely to lead to an upturn in demand over the forecast period. Introduction of hybrid techniques such as optical coherence tomography angiography (OCTA) can open up new pathways for the market. In August 2018, Conavi Medical launched the Novasight hybrid system for scanning coronary arteries. It has been used on a trial basis by Hamilton General Hospital, Canada, to check its efficacy and performance.

Some of the prominent names in the optical coherence tomography market include NIDEK Co., Ltd., Carl Zeiss AG, Terumo Corporation, Agfa Healthcare, KONINKLIJKE PHILIPS N.V, Imalux Corporation, Optovue, Abbott Laboratories, Boston Scientific Corporation, OPTOPOL Technology S.A, B. Braun Melsungen AG, Michelson Diagnostics, Heidelberg Engineering GmbH, Alcon, Novacam Technologies Inc., Topcon Corporation, Thorlabs Inc., and others.

Launch of new products are certain to get exposure owing to social media and prevalence of chronic diseases. This is evident by the launch of AngioVue by OptoVue in 2016. The trend is indicative of the pressing demand owing to launch of similar products such as AngioScan OCT by Nidek, DRI-Triton and 3D Oct-1 Maestro by Topcon.

Segmentation Analysis

The OCT market is segmented by technology, application, and device type.

By technology, spectral-domain OCT (SD-OCT), swept-source OCT, and others. The SD-OCT segment can command nearly 60.1% share of the OCT market by the end of the forecast period. On the other hand, the swept-source OCT segment can expand at a 9.1% CAGR over the aforementioned period.

Key applications of OCT include oncology, dermatology, ophthalmology, cardiology, and others. The ophthalmology segment can acquire close to 53.6% share of the market, while dermatology can grow at a brisk pace during the forecast period.

Types of OCT devices include tabletop OCT devices, catheter-based OCT devices, handheld OCT devices, and others.

Regions of prime interest to the market include The Americas, the Middle East & Africa (MEA), Asia Pacific (APAC), and Europe.

Access Report @ https://www.marketresearchfuture.com/reports/optical-coherence-tomography-market-1328

The Americas will lead the optical coherence tomography market owing to high ubiquitousness of diseases and presence of leading manufacturers. Prevalence of diabetic retinopathy and other age-related macular degeneration (AMD) are likely to induce demand for the market in the coming years. This market can touch a valuation of USD 558.34 million by 2023.

The Europe market has assumed the second position after Americas owing to funding gained for research & development by research institutes from governments and private sources. According to the 2017 report by the European Society of Retina Specialists (EURETINA), nearly 34 million suffer from AMD in the European Union.

The APAC OCT market is touted to grow at a rapid clip owing to technological advances in OCT devices. Growth opportunities in China, India, Malaysia, and other countries of South Asia and establishment of manufacturing units can bolster regional demand by 2023.

The MEA market can exhibit a sluggish growth rate during the forecast period owing to slowly developing economies in the African region.

Brows More Healthcare Related Research Reports:

Artificial Pancreas Device System Market Research Report–Global Forecast till 2023

Proteomics Market Research Report - Global Forecast till 2023

For More Details Please Visit @ Market Research Future

[isiawgr-blog]

Global Optical Coherence Tomography Market Challenges, Growth and Geographical Segmentation by 2023

Optical Coherence Tomography Market – Highlights

Market Research Future (MRFR) has recently published a study report giving out the complete market forecast up to 2023. In its analysis, MRFR confirms that the Global Optical Coherence Tomography Market will reach a valuation of USD 1483.49 million by 2023 with 8.9% CAGR throughout the review period (2017 – 2023).

Using the light instead of sound waves, the OCT technology provides high-resolution 3D images of all the major structures in the eye which are useful for the early detection of eye abnormalities along with cardiovascular issues such as diabetes, high blood pressure or high cholesterol. Providing non-invasive imaging tests that are simple to understand, OCT devices help availing the fastest diagnosis save a huge amount of time, eliminating the need for further consecutive tests.

The growing prevalence of neurovascular, coronary and other retina-related diseases fueled by the sedentary and changing lifestyle is doubling its market growth, increasing the demand for OCT.  Also, efforts & investments transpired into the R&D activities by the key market players are paying off well, fostering the market growth, bringing about improvements in the development of new devices.

Simultaneously, government initiatives are playing an integral role in the growth of OCT Devices. Technological advancements that took place in the field of medical science is also one of the key factors fostering market growth.

Optical Coherence Tomography Market - Key Players

Some of the fervent players operating in the market and profiled in MRFR analysis are Abbott Laboratories, Alcon, Carl Zeiss AG, B. Braun Melsungen AG, Terumo Corporation, Koninklijke Philips N.V, NIDEK Co., Ltd, Boston Scientific Corporation, Topcon Corporation, Heidelberg Engineering GmbH, Novacam Technologies Inc., OPTOPOL Technology S.A, Agfa Healthcare, Imalux Corporation, Thorlabs Inc., and Michelson Diagnostics. Profiling them in its analysis, MRFR finds out their strategies keeping them at the forefront of competition.

Get Free Sample @ https://www.marketresearchfuture.com/sample_request/1328

Optical Coherence Tomography Market - Segmentation

The Global Optical Coherence Tomography Market is segmented on the basis of technology, application, and type of devices.

Based on the technology, the optical coherence tomography market includes swept-source OCT, spectral-domain OCT (SD-OCT), and others.

Application-wise the optical coherence tomography market can be segmented into oncology, ophthalmology, cardiology, dermatology, and others.

Based on the type of devices, the optical coherence tomography market comprises handheld OCT devices, catheter-based OCT devices, tabletop OCT devices, and others.

Optical Coherence Tomography Market - Competitive Landscape

Optical Coherence Tomography market witnesses intensified completion owing to the several matured & small key players forming a competitive landscape. Innovation, mergers & acquisitions, and brand reinforcement remain the key trends for leading players.

Industry/Innovation/Related News:

January 28, 2019 A team of scientists at the Northwestern University (the US), published their study of a new tool, called spectral contrast optical coherence tomography angiography (SC-OCTA), that they have developed. The new tool, with its 3D-imaging technique, can images blood flow and detect subtle changes in the capillary organization through these tiny vessels, giving insight into this central portion of the human circulatory system which are useful for early diagnosis of diseases.

In January 2018, researchers from Sheridan University and Boston University have developed a fiber-based pull-back circumferential scanning OCT. The machine has an outer diameter of 6mm. With a bandwidth of 500-695 mm it can provide a high-resolution and contrasting image.

In November 2018, scholars from École Polytechnique de Montréal, Université de Montréal, and Université de Sherbrooke came up with automated dual-resolution serial optical coherence tomography (2R-SOCT) scanner, which has provided an image of the entire mouse brain with MRI inputs.

June 27, 2018 - Axsun Technologies, Inc. (US), one of the leading manufacturers of Swept Source Optical Coherence Tomography (SSOCT) engines, announced that it has shipped over 15,000 swept lasers for OCT imaging applications worldwide from the beginning of the year. The company further also stated that continuing expansion of its portfolio of Swept Laser Engines, it has added 140nm tuning bandwidth to its wide bandwidth 1060nm Swept laser. The new Swept Laser enables 3.5um axial resolution with superior speed and imaging depth over legacy OCT technologies.

May 30, 2018 – Heidelberg Engineering, Inc. (Germany), a high-tech imaging company specializing in the diagnostic equipment for ophthalmology announced that its next generation of its Spectralis imaging device OCT2 module is being sent into space by NASA. Since 2013, NASA researchers have been using the Spectralis optical coherence tomography (OCT) device to investigate the effects of a microgravity environment on vision. The OCT2 module will help retina specialist on the NASA space flight to image deeper structures in the eye that are affected by long-term space flight such as the posterior optic nerve head anatomy and the choroidal blood supply to the retina.

Optical Coherence Tomography Market - Regional Analysis

The Americas hold the largest share with nearly 37% of the global market share. Increasing occurrence of diabetic retinopathy and other eye diseases is one of the key factors driving the growth of the market. Moreover, there is a strong presence of market leaders. MRFR as predicted that region will reach an evaluation of approximately USD 558.34 million by 2023.

Europe follows the Americas lead and is expected to maintain a strong second lead due to supportive government policies and research & development carried out by private players is the primary propeller for the growth of the OCT market over the forecast period. The region is expected to closely follow the growth pattern of the Americas.

The Asia-Pacific region is predicted to be the fastest growing region with a CAGR of 9.4% during the forecast period. A massive patient population in the region with a rising incidence of eye diseases and diabetic retinopathy is expected to fuel rapid growth for the region. International market leaders are trying to enter this region, and this is likely to facilitate growth in the coming years further.

The Middle East & Africa are expected to experience limited growth. This is primarily due to the passive development in the African continent.

Browse Complete 85 Pages Premium Research Report Enabled with Tables and Figures @ https://www.marketresearchfuture.com/reports/optical-coherence-tomography-market-1328

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India +1 646 845 9312 Email: salesteam@marketresearchfuture.com

[vishwanathblr-blog]

Optical Coherence Tomography Market Research Report, CAGR around 8.9%  Analysis From -2023

Market Highlights

Optical coherence tomography technology has been evolved as one of the most important imaging technique in various medical applications. Over the years, the clinical applications of OCT have been exceeded to cardiology, gastroenterology, dentistry, dermatology, oncology, and many others. In the last few years, the demand for more precise information about coronary artery disease to achieve optimal treatment is boosting intravascular imaging. The OCT technology in this area has grown and is spreading, as it benefits both therapeutic and research purposes.

Rising prevalence of eye diseases, technological advancements, increasing application of optical coherence tomography, rising approval from regulatory bodies, and favorable reimbursements are the key factors driving the optical coherence tomography market.

However, the high cost of equipment may hinder the growth of the market to an extent. According to the study published in the Investigative Ophthalmology & Visual Science journal in 2016, instruments have advantages to operate at long wavelengths, faster imaging speeds, and longer imaging range than SD-OCT systems. But the market acceptance in ophthalmology is limited owing to the high costs, lack of clinical and normative data, and uncertainties caused by rapid technology evolution

Global optical coherence tomography market is expected to grow at a CAGR of 8.9% during the forecast period 2017–2023.

Key Players in the Optical Coherence Tomography Market

Some of key the players in the optical coherence tomography market are Carl Zeiss AG, Alcon, Abbott Laboratories, Terumo Corporation, KONINKLIJKE PHILIPS N.V, B. Braun Melsungen AG, Boston Scientific Corporation, Topcon Corporation, NIDEK Co., Ltd, Novacam Technologies Inc, OPTOPOL Technology S.A, Heidelberg Engineering GmbH, Optovue, Michelson Diagnostics, Thorlabs Inc., Agfa Healthcare, Imalux Corporation, and others.

Sample Report-   https://www.marketresearchfuture.com/sample_request/1328

  Regional Analysis

The Americas dominate the optical coherence tomography market owing to the increasing prevalence of prevalence of diabetic retinopathy, and other eye diseases, and the presence of the leading players in the region. According to the 2017 data suggested by Genentech, Inc., around 200,000 new cases of wet AMD are diagnosed in the United States each year. It is also reported that Diabetic retinopathy also impacts around 7.7 million Americans, and the number is expected to escalate to 11.3 million by 2030. Due to increasing acceptance of OCT systems multitude of products have been introduced by leading players, such as ARGOS by Santec, SPECTRALIS by Heidelberg, and others.  In November 2016, Carl Zeiss received FDA approval for PLEX Elite 9000, and commercially available in the United States.

Europe holds the second position in the optical coherence tomography market. The financial support provided by the government and private bodies for research & development is propelling the growth of the optical coherence tomography market in the European region. The prevalence of diabetic retinopathy and other eye diseases are also found to be very prevalent in the European region. As per the 2017 statistics suggested by European Society of Retina Specialists (EURETINA), it is found that age-related macular degeneration (AMD) currently affects nearly 34 million people in the European Union, and around 22 million people in the five most populous countries of Europe alone, i.e. Germany, the United Kingdom (UK), France, Italy and Spain.

Asia Pacific region is projected to be the fastest growing region during the forecast period. Rapid advancement in technology and rising participation of market players drive the growth of this market in Asia Pacific region. For instance, the first swept-source OCT was launched by Topcon in 2012, i.e. the DRI OCT Atlantis with 100,000 A-scans/s at the 1050-nm central wavelength. The system is approved in Europe (CE mark), but not approved for use in the U.S.

The Middle East and Africa hold the least share of the optical coherence tomography market owing to the presence of poor and slow developing countries, especially, in the African region.

    Segmentation

The global optical coherence tomography market is segmented on the basis of technology, application, and type of devices.

On the basis of the technology, the market is classified into spectral-domain OCT (SD-OCT), swept-source OCT, and others.

On the basis of the application, the market is segmented into cardiology, ophthalmology, dermatology, oncology, others.s

On the basis of the type of devices, the market is segmented into handheld OCT devices, tabletop OCT devices, catheter-based OCT devices, and others.

Market senariyo -  Optical coherence tomography (OCT) is non-invasive imaging technology. The device generates a false-color representation of the tissue structure, on the micron scale in situ and in real time.  The OCT is analogous to ultrasound imaging, except that it uses light instead of sound. Early OCT systems were based on time-domain (TD) optical technology, but in recent years, Spectral-domain OCT (SD-OCT) succeeded TD-OCT and addressed some of its limitations. The SD-OCT is 50-1000 times faster than the TD technique. The swept-source OCT (SS-OCT) has also attracted a great deal of attention in OCT market, as SS-OCT provides >200,000 A-scans/second with ~5-7 µm axial resolution.

  About Markets research future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

  Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +16468459312

Email: sales@marketresearchfuture.com

[insightfulblogz]

Angio Suites Market Analysis, Statistics, Segmentation, and Forecast to 2032

Angio suites, also known as interventional suites, are specialized medical facilities equipped with advanced imaging technologies to perform minimally invasive cardiovascular procedures. These suites are used for diagnostic and therapeutic interventions, such as angioplasty, stent placement, and catheterization, offering real-time imaging to guide physicians during the procedures. Angio suites combine high-resolution imaging with state-of-the-art equipment, enabling faster and more precise interventions with reduced patient risk. They are a critical component of modern cardiovascular care, improving outcomes for patients with heart disease, stroke, and peripheral vascular conditions.

The Angio Suites Market size was valued at USD 1245.0 million in 2022 and is expected to grow to USD 2104.20 million by 2030 and grow at a CAGR of 6.78% over the forecast period of 2023-2030.

Future Scope

The future of angio suites is closely tied to advancements in imaging technology and robotic-assisted interventions. As imaging techniques such as 3D imaging and augmented reality become more integrated into angio suites, physicians will be able to perform even more complex procedures with greater accuracy and safety. Robotic systems are also expected to play a larger role, allowing for enhanced precision and minimizing human error during delicate interventions. The continued development of artificial intelligence (AI) in medical imaging will further improve real-time decision-making and predictive analytics, enhancing the overall effectiveness of angio suites in cardiovascular care.

Trends

Several trends are shaping the evolution of angio suites. One of the most significant is the shift towards hybrid operating rooms that combine the capabilities of an angio suite with surgical equipment, enabling both minimally invasive and open procedures in the same setting. Another trend is the increasing use of robotic technology to assist in cardiovascular interventions, providing greater precision and reducing procedure times. Additionally, the integration of AI and machine learning in imaging analysis is transforming how data is interpreted, allowing for faster and more accurate diagnoses. Radiation dose reduction technologies are also becoming more common, ensuring patient and staff safety during prolonged procedures.

Applications

Angio suites are used in a variety of medical procedures aimed at diagnosing and treating cardiovascular conditions. These include coronary angiography, angioplasty, stent placements, and the treatment of aneurysms and peripheral artery disease. Angio suites are also essential for stroke treatment, where rapid imaging and intervention can significantly improve patient outcomes. In addition to cardiovascular interventions, angio suites are being increasingly used for non-vascular procedures, such as oncology treatments that require precise imaging for the placement of radioactive seeds or the delivery of targeted therapies.

Get a Free Sample Guide: https://www.snsinsider.com/sample-request/2846 

Key Points

Angio suites are advanced imaging facilities used for minimally invasive cardiovascular procedures.

They provide real-time, high-resolution imaging for precise and safe interventions.

Hybrid operating rooms and robotic-assisted interventions are major trends in angio suite technology.

Angio suites are essential for procedures such as angioplasty, stent placement, and stroke treatment.

The integration of AI and radiation dose reduction technologies is enhancing safety and outcomes.

Conclusion

Angio suites represent the pinnacle of modern cardiovascular care, offering advanced imaging capabilities that allow for safer, faster, and more precise interventions. As technology continues to evolve, with innovations in imaging, robotics, and AI, angio suites are set to become even more integral to the treatment of cardiovascular and other complex conditions. These state-of-the-art facilities are improving patient outcomes and redefining the standards of care for minimally invasive procedures.

[perfectlysizzlingpizza-blog]

Cardiopulmonary Stress Testing Systems Market is expected to grow at a CAGR of 8.20% by 2023

The global market for cardiopulmonary stress testing systems is anticipated to witness an 8.20% from 2015 to 2023 rising from a valuation of US$3.30 bn in 2014 to a valuation of US$6.67 bn by the end of 2023.” Based on product type, the global market for cardiopulmonary stress testing systems was led by CPET systems owing to the critical part this non-invasive plays for ascertaining skeletal, cardiovascular, hematopoietic, neuropsychological, and pulmonary muscle systems’ retort to exercise. Technological advancements are also likely to play a crucial role in the development of this segment. Regionally, North America is likely to witness a strong 7.3% CAGR over the forecast period and also rule the market meanwhile owing to the rising number cases of obesity in the region. The prevalence of leading players in North America is also likely to add up to the scenario.

View Full Report: http://www.transparencymarketresearch.com/cardiopulmonary-stress-testing-systems.html

The high rate of cardiovascular sicknesses has been the essential factor driving the demand for cardiopulmonary stress testing systems. As per the World Health Organization (WHO), the coronary artery diseases (CADs) represent almost 64% of the every one of the deaths because of cardiovascular conditions. Hence, this has been recognized as the key reason for a low quality of life for the larger part of ladies and men over the world. Attributable to these reasons the interest for cardiopulmonary stress testing systems has extensively ascended in the previous couple of years.

Request to view Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1530

The ascent in the geriatric populace over the world and the developing issue of weight have likewise brought about a sudden take-up of cardiopulmonary stress testing systems. The obese and the old are both inclined to the danger of coronary artery diseases (CADs), which has positively affected the worldwide market as of late. Innovative progressions, rising dispensable income, developing mindfulness about conceivable outcomes to treat cardiovascular infections, and infiltration of the modern technologies pertaining to monitoring have likewise brought about a higher conclusions rate, which has supported the demand for cardiopulmonary stress testing systems.

Request to Download TOC of the Report: http://www.transparencymarketresearch.com/report-toc/1530

The order of laws, for instance, the Affordable Care Act has been encouraging the healthcare division for cost control to give reasonable healthcare services to patients. This pattern has been hampering the worldwide market to a serious degree. The diminishment in the budget of healthcare services has provoked private firms and large hospitals to put less in new hardware and systems to have the capacity to offer a moderate healthcare in the more drawn out run. Moreover, exposure to hurtful radiation because of single-photon discharge figured tomography myocardial perfusion imaging (SPECT-MPI) systems has additionally demoralized the offers of these frameworks in the current past.

Global Cardiopulmonary Stress Testing Systems Market Market Report is available @ US$ 5795

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact us:

Transparency Market Research 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/

[isiawgr-blog]

Optical Coherence Tomography Market 2019 Analysis, Opportunities and Forecast to 2023

Optical Coherence Tomography Market – Highlights

Optical Coherence Tomography (OCT), an emerging technology for performing high-resolution cross-sectional imaging analogous to ultrasound imaging, using light instead of sound.  OCT non-invasive imaging test provide cross-section pictures retina, which helps diagnosis for glaucoma, AMD (age-related macular degeneration) and diabetic eye disease among other diseases of the retina. Similarly, these observations of retina are useful to perform coronary artery.  

Acknowledging the traction, the market is vibrating with; Market Research Future (MRFR) in its recently published study report asserts that the global Optical Coherence Tomography market gaining further prominence will register a spectacular growth of USD 1483.49 million by 2023, posting a striking CAGR of 8.9% during 2017 – 2023.

Factors such as favorable reimbursement policies, coupled with the ongoing product development & commercialization help boosting the market growth. OCT has been evolved as one of the most important imaging techniques in various medical applications. Hence, increasing applications of OCT, and rising approval from regulatory bodies account for some of the predominant factors, fueling the market growth.

Growing prevalence of coronary, neurovascular and other retina related diseases fueled by the changing lifestyle, and sedentary lifestyle are increasing the demand for OCT, increasing its market growth. Therefore, the global Optical Coherence Tomography market is growing pervasively. Technological advancements that took place in the field of medical science is also one of the key factors fostering the market growth.

Optical Coherence Tomography Market - Competitive Landscape

Optical Coherence Tomography market witnesses intensified completion owing to the several matured & small key players forming a competitive landscape. Innovation, mergers & acquisitions, and brand reinforcement remain the key trends for leading players.

Browse Complete 85 Pages Premium Research Report Enabled with Tables and Figures @ https://www.marketresearchfuture.com/reports/optical-coherence-tomography-market-1328

Optical Coherence Tomography Market - Key Players

Some of the fervent players operating in the market and profiled in MRFR analysis are Abbott Laboratories, Alcon, Carl Zeiss AG, B. Braun Melsungen AG, Terumo Corporation, Koninklijke Philips N.V, NIDEK Co., Ltd, Boston Scientific Corporation, Topcon Corporation, Heidelberg Engineering GmbH, Novacam Technologies Inc., OPTOPOL Technology S.A, Agfa Healthcare, Imalux Corporation, Thorlabs Inc., and Michelson Diagnostics. Profiling them in its analysis, MRFR finds out their strategies keeping them at the forefront of competition.

Industry/Innovation/Related News:

June 27, 2018 - Axsun Technologies, Inc. (US), one of the leading manufacturers of Swept Source Optical Coherence Tomography (SSOCT) engines, announced that it has shipped over 15,000 swept lasers for OCT imaging applications worldwide from the beginning of the year. The company further also stated that continuing expansion of its portfolio of Swept Laser Engines, it has added 140nm tuning bandwidth to its wide bandwidth 1060nm Swept laser. The new Swept Laser enables 3.5um axial resolution with superior speed and imaging depth over legacy OCT technologies.

May 30, 2018 – Heidelberg Engineering, Inc. (Germany), a high-tech imaging company specializing in the diagnostic equipment for ophthalmology announced that its next generation of its Spectralis imaging device OCT2 module is being sent into space by NASA. Since 2013, NASA researchers have been using the Spectralis optical coherence tomography (OCT) device to investigate the effects of a microgravity environment on vision. The OCT2 module will help retina specialist on the NASA space flight to image deeper structures in the eye that are affected by long-term space flight such as the posterior optic nerve head anatomy and the choroidal blood supply to the retina.

Optical Coherence Tomography Market - Key Finding

·         The Global Optical Coherence Tomography Market is expected to reach USD 1483.49 million by 2023 at a CAGR of 8.9%.

·         On the basis of the technology, Spectral-domain OCT (SD-OCT) is expected to command the largest market share of 60.1% over the review period, and Swept-source OCT is expected to grow at the fastest CAGR of 9.1% during the forecast period 2017-2023

·         On the basis of the Application, ophthalmology segment is expected to command the largest market share of 53.6% over the review period, and Dermatology is expected to grow at the fastest CAGR of 9.3% during the forecast period 2017-2023

·         The Americas hold the largest share of the global optical coherence tomography market and is expected to reach USD 558.34 million by 2023

·         Asia Pacific is the fastest growing market, which is expected to grow at a CAGR of 9.4% over the 2017-2023

Optical Coherence Tomography Market - Segmentation

The Optical Coherence Tomography Market can be segmented into four key dynamics;

By Technologies: Spectral-Domain OCT (SD-OCT), Swept-Source OCT and others.

By Applications: Ophthalmology, Dermatology, Cardiology, and others.

By Type of Devices: Table-top, Handheld, Catheter-Based OCT Devices and others.

By Regions: North America, Europe, APAC, and Rest-of-the-World (RoW).

The SD-OCT segment by technologies is estimated to acquire over 60% of the market share during the review period.

The Swept-source -OCT segment will witness over 9% CAGR during the assessment period.

The Ophthalmology segment, by applications, will command over 53% of the market share during the forecast period.

The Dermatology segment, by applications, will perceive more than 9% CAGR during the said period.

For More Information Visit @ https://www.medgadget.com/2019/01/optical-coherence-tomography-market-can-eye-for-an-8-9-cagr-with-alcon-carl-zeiss-agabbott-laboratories-etc-during-the-forecast-period-2017-2023.html

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India +1 646 845 9312 Email: salesteam@marketresearchfuture.com